Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Meloni

Showing results (211-220 of 242) with videos related to

Pageof 25
Sort By:
Acta Oto-Laryngologica|September 3, 1998
Epidemiology and treatment of otitis media with effusion in children in the first year of primary schoolP Marchisio, N Principi, D Passali, et al.
Blood|November 14, 1997
Autologous bone marrow transplantation for patients with myelodysplastic syndrome (MDS) or acute myeloid leukemia following MDS. Chronic and Acute Leukemia Working Parties of the European Group for Blood and Marrow TransplantationT De Witte, A Van Biezen, J Hermans, et al.
British Journal of Haematology|December 24, 1997
ALL R-87 protocol in the treatment of children with acute lymphoblastic leukaemia in early bone marrow relapseF Giona, A M Testi, R Rondelli, et al.
Biological Psychiatry|March 23, 2005
Antidepressant-like effects of cranial stimulation within a low-energy magnetic field in ratsWilliam A Carlezon, Michael L Rohan, Stephen D Mague, et al.
Annals of Hematology|July 2, 2003
High-dose hydroxyurea in the treatment of poor-risk myeloid leukemiasM C Petti, A Tafuri, R Latagliata, et al.
Annals of Hematology|April 1, 2014
Clofarabine in combination with a standard remission induction regimen (cytosine arabinoside and idarubicin) in patients with previously untreated intermediate and bad-risk acute myelogenous leukemia (AML) or high-risk myelodysplastic syndrome (HR-MDS): phase I results of an ongoing phase I/II study of the leukemia groups of EORTC and GIMEMA (EORTC GIMEMA 06061/AML-14A trial)R Willemze, S Suciu, P Muus, et al.
Bone Marrow Transplantation|July 1, 1996
Retrospective evaluation of autologous bone marrow transplantation vs allogeneic bone marrow transplantation from an HLA identical related donor in acute myelocytic leukemia. A study of the European Cooperative Group for Blood and Marrow Transplantation (EBMT)N C Gorin, M Labopin, L Fouillard, et al.
Leukemia|January 18, 2008
NPM1-mutated acute myeloid leukaemia occurring in JAK2-V617F+ primary myelofibrosis: de-novo origin?L Pasqualucci, S Li, G Meloni, et al.
Cancer|September 15, 1980
Discontinuing therapy in childhood acute lymphocytic leukemia. A multicentric survey in ItalyF Mandelli, S Amadori, A C Rajnoldi, et al.
Optics Express|July 21, 2015
Sub-Nyquist field trial using time frequency packed DP-QPSK super-channel within fixed ITU-T gridL Potì, G Meloni, G Berrettini, et al.
Pageof 25

Showing results (211-220 of 242) with videos related to

Sort By:
Pageof 25
Acta Oto-Laryngologica|September 3, 1998
Epidemiology and treatment of otitis media with effusion in children in the first year of primary schoolP Marchisio, N Principi, D Passali, et al.
Blood|November 14, 1997
Autologous bone marrow transplantation for patients with myelodysplastic syndrome (MDS) or acute myeloid leukemia following MDS. Chronic and Acute Leukemia Working Parties of the European Group for Blood and Marrow TransplantationT De Witte, A Van Biezen, J Hermans, et al.
British Journal of Haematology|December 24, 1997
ALL R-87 protocol in the treatment of children with acute lymphoblastic leukaemia in early bone marrow relapseF Giona, A M Testi, R Rondelli, et al.
Biological Psychiatry|March 23, 2005
Antidepressant-like effects of cranial stimulation within a low-energy magnetic field in ratsWilliam A Carlezon, Michael L Rohan, Stephen D Mague, et al.
Annals of Hematology|July 2, 2003
High-dose hydroxyurea in the treatment of poor-risk myeloid leukemiasM C Petti, A Tafuri, R Latagliata, et al.
Annals of Hematology|April 1, 2014
Clofarabine in combination with a standard remission induction regimen (cytosine arabinoside and idarubicin) in patients with previously untreated intermediate and bad-risk acute myelogenous leukemia (AML) or high-risk myelodysplastic syndrome (HR-MDS): phase I results of an ongoing phase I/II study of the leukemia groups of EORTC and GIMEMA (EORTC GIMEMA 06061/AML-14A trial)R Willemze, S Suciu, P Muus, et al.
Bone Marrow Transplantation|July 1, 1996
Retrospective evaluation of autologous bone marrow transplantation vs allogeneic bone marrow transplantation from an HLA identical related donor in acute myelocytic leukemia. A study of the European Cooperative Group for Blood and Marrow Transplantation (EBMT)N C Gorin, M Labopin, L Fouillard, et al.
Leukemia|January 18, 2008
NPM1-mutated acute myeloid leukaemia occurring in JAK2-V617F+ primary myelofibrosis: de-novo origin?L Pasqualucci, S Li, G Meloni, et al.
Cancer|September 15, 1980
Discontinuing therapy in childhood acute lymphocytic leukemia. A multicentric survey in ItalyF Mandelli, S Amadori, A C Rajnoldi, et al.
Optics Express|July 21, 2015
Sub-Nyquist field trial using time frequency packed DP-QPSK super-channel within fixed ITU-T gridL Potì, G Meloni, G Berrettini, et al.
Pageof 25